By the WoundSource Editor
Irving, TX – January 24, 2017 – Keneric Healthcare, a medical device company that offers innovative and cost effective patient care products, today announced their partnership with Angelini Pharma Inc. This partnership will expand the reach of both companies by leveraging their clinical advocates, market share and areas of expertise.
Angelini Pharma Inc. is expanding their existing product portfolio to now include Keneric Healthcare's RTD™ Wound Dressing (antibacterial/antifungal). RTD™ wound dressing is a proprietary highly absorbent antimicrobial foam with the only successful combination of Methylene Blue (0.25 mg/g), Gentian Violet (0.25 mg/g) and Silver Ion (7 mg/g) integrated into the polymer matrix available in the market. Healthcare providers continue to share their clinical appreciation for RTD™s ability to actively degrade and remove biofilm, to include preventing the ability of bacteria to become resistant. The successful removal of biofilm and exudate, ensures the body can resume its natural healing process leading to wound closure.
Al Henry, CEO, Keneric Healthcare stated, "Our decision to combine efforts with Angelini to further promote our RTD™ antimicrobial dressing will further increase the number of patients and practitioners that can experience RTD™s proven efficacy."
Todd Maddock, the CEO of Angelini U.S. stated, "We are excited to add Keneric's RTD Dressing to our product portfolio. We look to provide healthcare professionals and patients with a range of wound treatment options based on innovative technologies like Keneric's RTD™ Wound Dressing."
If you would like more information about this topic, please call:
Keneric Healthcare - Adolph Escobedo at 972-666-4928
Angelini Pharma Inc. - Steven Adler at 800-726-2308
SOURCE Angelini Pharma Inc.
About Keneric Healthcare
Based in Irving, Texas, Keneric Healthcare manufactures and distributes RTD™, a line of advanced wound care products. RTD™ is the only dressing that combines the antimicrobial and antifungal properties of methylene blue and gentian violet with the added benefits of silver. Keneric Healthcare provides innovative wound care products that address the multiple priorities of wound healing while supporting the economic and time-saving needs of healthcare providers.
RTD™ is FDA cleared and is indicated for the treatment of partial to full thickness wounds with moderate to heavy exudate. RTD™ is available in various sizes and thicknesses.
About Angelini Pharma Inc.
Angelini is a privately-held, mid-sized international manufacturer and marketer of pharmaceutical and healthcare products in the pharmaceutical and mass-market sectors. Founded in Italy in 1919, the group has operations in 20 countries and employs 5,000 people. Angelini Pharma Inc. is the American business unit of Angelini, providing innovative solutions to promote infection control, antisepsis, disinfection, and wound healing to our targeted customers.